These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7519907)

  • 41. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of the mechanical characteristics of benign prostatic tissue: a novel method for assessing benign prostatic disease.
    Phipps S; Yang TH; Habib FK; Reuben RL; McNeill SA
    Urology; 2005 May; 65(5):1024-8. PubMed ID: 15882757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of flutamide and hydroxy-flutamide on the growth of human benign prostatic hyperplasia cells in primary culture: a preliminary report.
    Hallowes R; Cox S; Hayward S; Deshpande N; Towler J
    Anticancer Res; 1991; 11(5):1799-805. PubMed ID: 1722658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Animal models for benign prostatic hyperplasia.
    Hieble JP
    Handb Exp Pharmacol; 2011; (202):69-79. PubMed ID: 21290222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative-comparative histology of prostatic adenomas in medically and surgically treated patients.
    Dutkiewicz S; Kałczak M
    Int Urol Nephrol; 1994; 26(4):455-60. PubMed ID: 7528179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.
    Arivazhagan J; Nandeesha H; Dorairajan LN; Sreenivasulu K
    Aging Male; 2017 Jun; 20(2):115-118. PubMed ID: 28590830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Is a single prostatic biopsy sufficient for selection of medical treatment in benign prostatic hypertrophy?].
    Zlotta AR; Sattar AA; Wespes E; Haot J; Schulman CC
    Acta Urol Belg; 1995 Mar; 63(1):83-7. PubMed ID: 7537013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
    Zhao H; Ramos CF; Brooks JD; Peehl DM
    J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc induces a bell-shaped proliferative dose-response effect in cultured smooth muscle cells from benign prostatic hyperplasia.
    Adolfsson PI; Bloth B; Hägg S; Svensson SP
    Urology; 2015 Mar; 85(3):704.e15-9. PubMed ID: 25733304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.
    Peehl DM; Sellers RG
    Exp Cell Res; 1997 May; 232(2):208-15. PubMed ID: 9168795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
    Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
    Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remodeling of the muscle layer (detrusor muscle) of hyperactive bladder disease in patients with benign prostatic hyperplasia.
    Nepomnyashchikh LM; Lushnikova EL; Neimark AI
    Bull Exp Biol Med; 2012 Sep; 153(5):778-83. PubMed ID: 23113284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
    Byun SS; Jeong H; Jo MK; Lee E
    Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benign prostatic hyperplasia: morphometric studies in relation to the hormone sensitivity of stromal tissue.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Höpfl R; Rohr HP
    Prog Clin Biol Res; 1994; 386():51-65. PubMed ID: 7528421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.